Treatment of rhinoorbital mucoromycosis in a multimorbid patient (clinical case)
Year: 2025, volume 21 Issue: №2 Pages: 132-136
Heading: Otorhinolaryngology Article type: Case report
Authors: Mironchenkov M.V., Charushin А.О., Khostelidi S.N., Charushina I.P., Gavrilova T.V.
Organization: North-West State Medical University n.a. I.I. Mechnikov, Department of Neuropathology Assistant Professor, Candidate of Medical Science, Perm State University of Medicine n.a. Academician Ye.A. Vagner of Ministry of Health of the Russian Federation
Heading: Otorhinolaryngology Article type: Case report
Authors: Mironchenkov M.V., Charushin А.О., Khostelidi S.N., Charushina I.P., Gavrilova T.V.
Organization: North-West State Medical University n.a. I.I. Mechnikov, Department of Neuropathology Assistant Professor, Candidate of Medical Science, Perm State University of Medicine n.a. Academician Ye.A. Vagner of Ministry of Health of the Russian Federation
Summary:
A clinical case of a rare orbital lesion with mucormycosis, which developed against the background of odontogenic osteomyelitis in a patient with diabetes mellitus, is presented. A comprehensive approach, including antifungal therapy, surgical interventions and correction of carbohydrate metabolism, made it possible to localize the infection and stabilize the patient's condition; however, vision in the right eye could not be restored.
Bibliography:
1. Jeong W, Keighley С, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: A systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25 (1 ):26-34. DOM0.1016/j.cmi.2018.07.011
2. Sharma A, Alam MA, Dhoundiyal S, et al. Review on mucormycosis: Pathogenesis, epidemiology, microbiology and diagnosis. Infect Disord Drug Targets. 2024;24 (1 ):e220823220209. DOM 0.2174/1871526523666230822154407
3. Amanati A, Barzegar H, Pouladfar G, et al. Orbital mucormycosis in immunocompetent children; review of risk factors, diagnosis, and treatment approach. ВМС Infect Dis. 2020;20(1 ):770. DOM 0.1186/s12879-020-05460-2
4. Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries. Lancet Microbe. 2022;3(7):e543-52. DOM 0.1016/S2666-5247(21)00237-8
5. Garlapati K, Chavva S, Vaddeswarupu RM, et al. Fulminant mucormycosis involving paranasal sinuses: A rare case report. Case Rep Dent. 2014;2014:465919. DOM 0.1155/2014/465919
6. Klimko NN, Khostelidi SN, Volkova AG, et al. Mucormycosis in haematological patients: Case report and results of prospective study in Saint Petersburg, Russia. Mycoses. 2014;57(Suppl.3):91-6. DOM 0.1111/myc.12247
7. Uzbek L, Topcu U, Manay M, et al. COVID-19-associated mucormycosis: A systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023;29 (6):722-31. DOM0.1016/J. cmi.2023.03.008
8. Charushin АО, Khostelidi SN, Charushina IP, et al. Comparative assessment of cases of mucormycosis of the paranasal sinuses in the Russian Federation during the COVID-19 period and beyond. Problems of Medical Mycology. 2023;25 (2):198.
9. Khostelidi SN, Zaitsev VA, Vartanyan SA, et al. Mucormycosis in patients with COVID-19 in Russia: Results of a prospective multicenter study. Journal of Infectology. 2022;14 (2):116-27. DOM0.22625/207 2-6732-2022-14-2-116-127
10. Salmanton-Garcia J, Koehler Р, Kindo A, et al. Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope®-Global Registry for Emerging Fungal Infections. J Infect. 2020;81(5):802-15. DOI:10.1016/j.jinf. 2020.08.015
11. Klimko N, Kozlova Y, Khostelidi S, et al. The burden of serious fungal diseases in Russia. Mycoses. 2015;58 (Suppl. 5):58-62. DOM0.1111/myc.12388
12. Prakash H,ChakrabartiA. Epidemiology of mucormycosis in India. Microorganisms. 2021;9(3):523. DOM0.3390/microorg anisms9030523
13. Charushin АО, Khostelidi SN, Borovinsky Rl, et al. A case of successful treatment of rhinoorbital mucormycosis in a patient with COVID-19 in the Perm region. Problems of Medical Mycology. 2022;24 (3):13-9. DOI:10.24412/1999-6780-2022-3-13-19
14. Boyko NV, Kolesnikov VN, Khanamirov АА, et al. COVID-19-associated syno-orbital mucormycosis. Russian Bulletin of Otorhinolaryngology. 2023;88(2):31-7. DOI: 10.17116/otorino20228802131
15. Kolsanov AV, Zelter PM, Zeleva OV, et al. Clinical and anatomical characteristics of patients with rhinoorbitocerebral mucormycosis. Bulletin of the Russian Academy of Medical Sciences. 2022;77(6):381-90. DOM0.15690/vramn2193
16. Hadzri MH.Azarisman SM, FauziAR, KahairiA. Invasive rhinocerebral mucormycosis with orbital extension in poorly-controlled diabetes mellitus. Singapore Med J. 2009;50(3):e107-9. PMID:19352553
17. Vaughan C, Bartolo A, Vallabh N, et al. A meta-analysis of survival factors in rhino-orbital-cerebral mucormycosis— Has anything changed in the past 20 years? Clin Otolaryngol. 2018;43 (6):1454-64. DOM 0.1111/coa.13175
18. SenM, HonavarSG, BansalR,etal. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India — Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021 ;69(7):1670-92. DOM 0.4103/ijo.UO_1565_21
19. Comely OA, Alastruey-lzquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology
in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis. 2019;19(12):e405-21. DOM0.1016/S1473-3099(19)30312-3
20. Yohai RA, Bullock JD, Aziz AA, et al. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol. 1994;39 (1):3-22. DOI:10.1016/s0039-6257(05)80041-4
| Attachment | Size |
|---|---|
| 2025_02_132-136.pdf | 1.17 MB |
Русский
English